Inflect Capital

Quality healthcare should be accessible to everyone At Healthworx we enable solutions that increase healthcare quality, affordability and accessibility for all. We simplify innovation in healthcare to create real value and improve lives. We're focused on creating a healthier future and a better healthcare experience, and are looking for the best ideas to help us redefine healthcare.

We’re making healthcare massively better by investing in the next generation of entrepreneurs, advising major corporations on what matters in digital health, and working to scale health equity for all humanity. Rock Health Capital makes healthcare massively better for every human being by investing in remarkable entrepreneurs working at the intersection of healthcare and technology.

We believe that the future of modern healthcare is led by a digital revolution. Investing in solutions that help to transforms these challenges healthcare is facing. When technology is fuelled by digitalisation, innovation will thrive and grow, creating leverage for global reform. By supporting innovative digital-health startups with seed capital, extensive industry knowledge and a powerful global network, we aim to change the future of healthcare forever. Entrepreneurial capital: Our work is rooted in a deep understanding of the system in which we operate. Pioneering: We believe that the future of modern healthcare is led by a digital revolution. Committed to impact: There is an idealistic element to our proposition. The aim of our efforts is change. Human centred: People are at the core of everything we do. They are the end to our means and the why to our what. From a business perspective this translates into a strong desire to invest in a team, rather than a business plan. We believe in long term shared success. The Approach In return for the invested capital and support, Healthy.Capital acquires a minority share. We are: Team with experts Entrepreneurs by heart Specialist in building product-market fit Long term investment relationships Digital Health VC with international network Ecosystem key player Our initially invested capital ranges between EUR 200K and EUR 1 M. Once a board, and depending on the proposition, we will offer support with a startup mentality in the following areas: Strategy Building Coaching Operational Expertise Business Development Health & Care Expertise Co-investments Financial Roadmap Planning Network Expansion Healthy.Capital invests in talented founders & teams. Our focus is Digital Health Solutions Services SaaS Marketplaces Our Criteria Business entity registered in the Netherlands Company younger than 7 years old Tech component (pre-)Seed stage Excellent teams Data driven DNA Strong problem-solution fit High scalability with healthy profitability

Rubicon seeks to both invest and partner to build meaningful businesses that create enduring value by transforming the way people receive healthcare. Rubicon’s approach to investing is guided by a deliberative analytic process building ground-up businesses from scratch, as well as empowering large platform and special opportunity companies. GROUND UPWe partner to create transformational companies because we believe there are better ways to solve today’s healthcare challenges. Our ground up business concepts apply data-driven processes to identify value edge, a form of competitive advantage, and combine with mission driven teams. PLATFORM & SPECIAL OPPORTUNITIESWe partner with exceptional companies that create value by transforming lives. We focus on unique healthcare assets that pioneer healthcare solutions.

The world has hard problems to solve, and answers are urgently needed. We help entrepreneurs on a mission to solve these hard problems build companies. We believe Singapore has the resources and capabilities to tackle the pressing challenges impacting people around the world. SGInnovate has been established to help these ambitious and capable people to build 'technology-intensive' products borne out of scientific research, leveraging the full power of the Singapore ecosystem to achieve this mission. Investment Capital Singapore has over $1b+ of private-market funds and another $1b+ of public-sector funds. Government Singapore remains one of the most attractive and trusted places to build companies, in large part due to our economic competitiveness, as well as political and operational stability. Research A global research and innovation hub, S$25B has been committed to Singapore's latest Research, Innovation and Enterprise (RIE) five-year plan, covering domains such as healthcare, sustainability and manufacturing, through to 2025. Corporate Backing Singapore brings together over 7000 regional and global corporations who represent go-to-market help, joint product development, investment funding and possible exits. World Class Institute of Higher Learning Singapore is home to two of the top 20 globally-ranked universities.

We are inspired by a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We invest in both solutions intended for use in the diagnosis or cure of disease and solutions designed to help healthcare organizations - be them hospitals, biopharmas, insurers, etc. - be better at what they do. We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and invest in founders determined to effectively and efficiently serve these participants on the european continent, where we are based, and internationally.​ In our investment criteria and process, we are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology. To learn more about the methodology, head to The Student Guide to Biodesign, developed by a team of Stanford instructors and students who are passionate about education and making high-quality learning materials available and accessible to all.​ We invest in european companies as well as in selected non-european companies with ties to europe. Wherever they are, our goal is to help founders ready their companies to raise series A capital, and to access international markets. To learn more about our process, click here.